Zobrazeno 1 - 4
of 4
pro vyhledávání: '"C L, Bogert"'
Autor:
R, Calaluce, D L, Earnest, D, Heddens, J G, Einspahr, D, Roe, C L, Bogert, J R, Marshall, D S, Alberts
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 9(12)
Prostaglandin E2 (PGE2) has served as a surrogate end point biomarker in colorectal tumor progression. Colonic mucosa PGE2 levels of patients with colorectal adenomas or carcinomas have been shown to be higher than in control subjects. Our dose-findi
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 4(3)
It has been demonstrated and confirmed that certain nonsteroidal anti-inflammatory drugs which inhibit cyclooxygenase and the synthesis of prostaglandins and other eicosanoids, can reduce the formation of both colon polyps and cancers in experimental
Autor:
R J, Knapp, S D, Sharma, G, Toth, M T, Duong, L, Fang, C L, Bogert, S J, Weber, M, Hunt, T P, Davis, J K, Wamsley
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 258(3)
[D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin ([125I]DPDPE) is a highly selective radioligand for the delta opioid receptor with a specific activity (2200 Ci/mmol) that is over 50-fold greater than that of tritium-labeled DPDPE analogs. [125I]DPDPE binds to
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 255(3)
[N-methyl-Nle28,31]CCK26-33 (SNF 8702) is a nonsulfated cholecystokinin octapeptide analog that is highly selective for cholecystokinin-B (CCK-B) receptors. Inhibition studies using [125I] Bolton-Hunter-labeled CCK-8 show that SNF 8702 has over 4,000